Currently, no consensus exists regarding the definition of oligometastatic pancreatic ductal adenocarcinoma, its necessary diagnostic measures, and potential treatment approaches. To address these ...

A family say they have been ‘overwhelmed’ by the outpouring of support from strangers as they face one of the most difficult times of their lives ...

This Colorectal Cancer Awareness Month, we stand alongside every citizen courageously battling colon or rectal cancer, we pay tribute to those who lost ...

A report published March 2 by the American Cancer Society found that colorectal cancer rates among adults 65 and older ...

Rectal cancers on their own, however, are rising in all adults, and now account for nearly one-third of all colorectal cancer diagnoses, up from 27% in the mid-2000s, the report found. Between 2018 ...

Delcath Systems, Inc.’s Q3 revenue was pressured by weak patient starts, but 2026 growth prospects remain strong. Click for how DCTH stock valuation looks low.

Colorectal liver metastases (CRLM), cancer that has spread from the colon or rectum to the liver, have a deadly reputation. Due to its pervasive spread, typical cancer treatments like chemotherapy and ...

ImmunityBio (NASDAQ: IBRX) recently announced a partnership with Accord Healthcare to expand European access to ANKTIVA for bladder cancer patients across 33 countries. ANKTIVA achieved a 71% complete ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...

The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancerPivotal results from the Phase 3 portion with mFOLFOX6 of the ...